title: CpG motifs induce Langerhans cell migration in vivo.
abstract: Cytosine-guanosine (CpG) oligonucleotide (CpG-oligo) sequences are immunostimulatory motifs that are present in bacterial DNA and their presence in plasmids might contribute to the immune response generated by DNA vaccination. The cell targets of CpG motifs in vivo have not been characterized yet. In this report we assessed the in vivo effects of CpG motifs on Langerhans cells (LC) migration. We showed that intradermal injection of 10 microg of CpG-containing oligonucleotides in mouse ear induced the local depletion of LC within 2 h of exposure as shown by CD11c and Ia immunohistological staining. To demonstrate that LC depletion was due to LC migration, CpG oligonucleotides were injected into the explants ex vivo, and the CD11c(+) cells emigrating from the cultured isolated skin within medium were evaluated by immunostaining and FACS analysis. Our findings demonstrate that CpG motifs induce LC/dendritic cell (DC) migration out of the skin. To assess whether CpG motifs may act directly on LC/DC to induce their emigration we next analyzed the effects of CpG motifs in vitro on the expression of adhesion molecules involved in LC/DC migration. The results of these experiments show that alpha(6) integrins, E-Cadherin, ICAM-1, CD11b and CD11c were differentially regulated upon CpG-oligo treatment of immortalized DC. CpG treatment (10 microg/ml for 8 h) resulted in a 100% increase in ICAM-1 staining intensity, a 50% decrease in E-Cadherin staining and a 25% decrease in alpha(6) integrins staining, while no changes in the levels of CD11b and CD11c expression were recorded. Changes in adhesion molecule expression were mirrored by concomitant changes in the cell morphology that included cell depolarization, the appearance of filopods and loss of adherence. This study provides the first in vivo evidence that CpG motifs signal the migration of LC from the epidermis.
authors.affiliation: INSERM U167, Institut Pasteur de Lille, 59019 Lille Cedex, France.
authors.forename: E
authors.initials: E
authors.lastname: Ban
authors.forename: L
authors.initials: L
authors.lastname: Dupré
authors.forename: E
authors.initials: E
authors.lastname: Hermann
authors.forename: W
authors.initials: W
authors.lastname: Rohn
authors.forename: C
authors.initials: C
authors.lastname: Vendeville
authors.forename: B
authors.initials: B
authors.lastname: Quatannens
authors.forename: P
authors.initials: P
authors.lastname: Ricciardi-Castagnoli
authors.forename: A
authors.initials: A
authors.lastname: Capron
authors.forename: G
authors.initials: G
authors.lastname: Riveau
mesh_terms: D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D015226:Dinucleoside Phosphates / Q000494:pharmacology*; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007801:Langerhans Cells / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009841:Oligonucleotides / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects; D019444:Vaccines, DNA / Q000276:immunology
chemical_list: D015226:Dinucleoside Phosphates; D018799:Intercellular Adhesion Molecule-1; D009841:Oligonucleotides; D019444:Vaccines, DNA; C015772:CpG dinucleotide